SOHO20
Does the Addition of Ixazomib to Lenalidomide and Dexamethasone Improve Survival in MM?
Myeloma | November 14, 2022
A study presented at the 2020 Society of Hematologic Oncology Annual Meeting found that the addition of ixazomib to ...
Read More
Black Patients with Multiple Myeloma See Improved Response with Daratumumab-Based Regimen
Rob DillardMyeloma | November 14, 2022
The addition of daratumumab to standard therapy improved responses in Black transplant-eligible patients with newly diagnosed ...
Read More
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Editorial Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |